Visit Our Blog
  • About FDNA
  • Products
    • Face2Gene Clinic
    • Face2Gene Labs
  • Contact
  • Blog
  • News & Publications
  • Blog

Categories
  • All
  • ACMG
  • Case Study
  • Diagnostic odyssey
  • Events/Conferences
  • Face2Gene
  • Geneticist profile
  • Genomics
  • Phenotyping
  • Rare Diseases
  • Scientific Abstracts
  • Talks
  • Technology
  • Uncategorized
  • Videos

Drug Delivery Partnership: Precision Medicine Drives Discovery, Development and Commercialization in Pharma

January 22, 2018

By Molly Shuttlesworth

Events/Conferences,Genomics,Phenotyping,Technology

In an era of breakthrough advancements in healthcare, it is hard to believe that 90% of blockbuster medicines are only effective for 30-50% of patients. The reason? A “one-size-fits-all” approach to pharmaceutical development and commercialization.

At this year’s 22nd Annual Drug Delivery Partnership meeting, a new approach to the pharma value chain is in discussion. Speaker Barry Frankel explores the power of precision medicine for pharma in his talk, Enabling Drug Development: Artificial Intelligence, Phenotypes and Genomics Integrated for Precision Medicine. Precision medicine aims to personalize healthcare, factoring in individuals’ traits—genetics, lifestyle, etc.—to develop targeted approaches to diagnosis, treatment and prevention for patients.

The incorporation of genomic information into pharmaceutical development is on the rise; Frankel highlights that genomics adoption is now faster than Moore’s Law*. However, the industry is still facing barriers to full-on adoption. Drugs based on genetic targets have a success rate 1.5-2X better than their counterparts that don’t include genetic information, but identifying the genetic variant causing a disease is like trying to find a needle in a haystack.

In steps FDNA and their deep learning technology. The technology captures physiological information, biometric data—such as facial photos—and clinical notes, curated in a proprietary database, to identify disease-causing genetic variants with higher accuracy in a process called “next-generation phenotyping” (NGP).

 

NGP is the use of computational techniques to integrate phenotypic data into the analysis of human health, including the capturing, structuring, and interpretation of complex clinical information. The correlations found between phenotypic data and genomic data improve and accelerate targeted diagnostics, therapeutics development, and patient care.

 

 

“We estimate that the addition of phenotypic features increases the diagnostic yield to about 60% (from 25% without).  When adding facial analysis, FDNA’s technology, to that process, the diagnostic yield increases to more than 85%.”  Dr. Peter Krawitz University Hospital Bonn, Germany, Principal Investigator of PEDIA

 

NGP has the capacity to compliment NGS across the entire Pharma chain, from discovery to development to commercialization. NGP helps researchers identify and target disease biomarkers, enable earlier and more targeted patient diagnosis for trial recruitment and personalize therapeutic approaches.

 

 

Interested in learning more about using NGP for the benefit of your development and commercialization activities? Learn more at www.FDNA.com

 

*Source:  National Institute of Health, National Human Genome Research Institute (7/17), Biology Reference, Illumina

More entries about Events/Conferences

Rare Diseases
 

A Rare Disease Day Reflection

Rare diseases affect roughly 30 million Americans, yet only 5 percent of the estimated 7,000 known rare diseases have cures Read more

Events/Conferences
 

What to Do and See at ASHG 2018

San Diego, CA – The FDNA team is excited to be back at the American Society of Human Genetics (ASHG) Read more

Events/Conferences
 

AI in Healthcare: Separating the Hype from the Hope

FDNA’s CEO Dekel Gelbman recently spoke to hundreds of leaders during the Stanford Big Data in Precision Health Summit. The Read more

Events/Conferences
 

FDNA and Face2Gene Featured at ESHG

  A flock of researchers from around the globe shared their findings in dysmorphology and molecular genetics at this year’s Read more

Events/Conferences
 

What to Do and See at ESHG

The European Society of Human Genetics (ESHG) 42nd Annual  Meeting 2018 MiCo – Milano Congressi · Milan, Italy · June Read more

Events/Conferences
 

The Road to Precision Medicine: Balancing Ethics and Efficiency

Artificial intelligence has increasingly become the basis for advancing precision medicine. Tomorrow, at the ReWork Deep Learning in Healthcare Summit Read more

Events/ConferencesFace2GeneTalks
 

FDNA’s Keynote at ePharma: Using Next-Generation Phenotyping For Precision Medicine Across the Pharma Value Chain

NOTE: This post is based on a presentation made at the March 2018 ePharma conference in New York City.   Read more

Events/Conferences
 

What to Do and See at ACMG

The American College of Medical Genetics (ACMG) Annual Clinical Genetics Meeting 2018 Charlotte Convention Center · Charlotte, North Carolina · April 10-14, 2018 Read more

Events/Conferences
 

Greenwood Genetic’s Journey: Partnering to Improve Precision Medicine

In its 44 year history, Greenwood Genetic Center (GGC) has seen over 80,000 patient cases. That’s a lot of data. Read more

Events/Conferences
 

Happening at HIMMS: Precision Medicine Through Next-Generation Phenotyping—A Customer’s Journey

HIMSS Conference, Microsoft booth Thursday, March 7 3:40 PM PST Las Vegas, Nevada   As over 40,000 health IT professionals, Read more

Events/Conferences
 

FDNA Announces Genomics Collaborative® at a Global Innovation Summit

English | Spanish In a packed auditorium at Mexico City’s CENTRO University, FDNA’s Senior Director of Marketing, Jeff Daniels, announced Read more

Events/Conferences
 

Drug Delivery Partnership: Precision Medicine Drives Discovery, Development and Commercialization in Pharma

In an era of breakthrough advancements in healthcare, it is hard to believe that 90% of blockbuster medicines are only Read more

Events/Conferences
 

What to Do and See at ASHG

The American Society of Human Genetics 67th Annual Meeting (ASHG 2017) Orange County Convention Center · Orlando, Florida October 17-21, Read more

Events/Conferences
 

FDNA Presents Rare Disease Technologies at the 2017 Precision Medicine Summit at Boston Children’s Hospital

The Division of Genetics and Genomics Department of Medicine at Boston Children’s Hospital will present their exciting new Fall Precision Read more

Events/Conferences
 

Disorder: The Rare Disease Film Festival

Disorder: The Rare Disease Film Festival will be held October 2 & 3, 2017 in Boston, MA. This is a new event Read more

Events/Conferences
 

What to Do and See at ESHG 2017 in Copenhagen

Annual Clinical Genetics Meeting (ESHG 2017) Bella Center Copenhagen, Copenhagen, Denmark May 27-30, 2017 Copenhagen, Denmark – The time is yet again Read more

Rare Diseases
 

New Facial Analysis Discoveries for RASopathy Syndromes in the Year of Discovery

  In March, FDNA reached out to clinicians and patients globally as part of the Year of Discovery to collect Read more

Rare Diseases
 

FDNA Partners with Blueprint Genetics to Spotlight RASopathies During the Year of Discovery

FDNA’s Year of Discovery Initiative will spotlight a different genetic syndrome group each month as part of their mission to Read more

Events/Conferences
 

What to Do and See at ACMG 2017 in Phoenix, AZ

Annual Clinical Genetics Meeting (ACMG 2017) Phoenix Convention Center, Phoenix, Arizona March 21-25, 2017 Phoenix, Arizona – With ACMG just over Read more

Rare Diseases
 

FDNA Launches “Year of Discovery” for Rare Disease Day

FDNA Launches “Year of Discovery” for Rare Disease Day Boston-based health and tech start-up calls on patients and clinicians to share Read more

  • Contact Us
  • Privacy Policy
  • Terms of Use

Signup for News


* These fields are required.

© 2011-2022 FDNA INC. www.FDNA.com. All rights reserved.

Face2Gene is a search and reference tool provided for informational purposes and not intended to replace the clinician’s judgment or experience, nor should it be used to diagnose or treat medical conditions.